Skip to Content

Zynerba Pharmaceuticals Inc

Rating as of

Company Profile

Business Description

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

Contact
80 West Lancaster Avenue, Suite 300
Devon, PA, 19333
T +1 484 581-7505
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 28